Our research aims to examine physical and mental health across various contexts, to translate findings to create or enhance psychosocial interventions that promote well-being. Areas of central focus are coping with (advanced/metastatic) cancer, internalizing symptoms with significance for disability/mortality (depressive, physical/somatic, traumatic stress), Asian American or limited English proficiency populations, and the role of trauma or chronic adversity.
Undergraduates: application instructions published
Our multidisciplinary team leverages the expertise of neurobiologists, neuro-ophthalmologists, neurosurgeons, cell biologists, engineers, and electrophysiologists to develop therapies to increase neuro-plasticity to drive regeneration of the optic nerve to restore vision to millions of patients world-wide blinded by glaucoma and other diseases of the optic nerve.
Understanding of the molecular basis of age-related macular degeneration and inherited retinal degeneration; Illuminating the path toward the development of new vision therapies
To understand the molecular basis of SBMA disease pathogenesis, we introduced the entire AR gene with 100 CAG repeats on a yeast artificial chromosome (YAC) into mice, and successfully recapitulated the SBMA phenotype of neurogenic atrophy and motor neuron loss in a mouse model.
We unite novel nanomaterials, wireless bioelectronics, artificial intelligence, and 3D/4D nanomaterials printing to create multimodal wearables, self-powered electronic skins, and human tissue models. Our platforms advance molecular and physiological health monitoring, disease research, and personalized medicine while enabling intuitive human–machine interfaces for robotic control and immersive augmented and virtual reality (AR/VR) experiences.
We are generally interested in the study of the brain as a complex dynamical system, including signal processing of neural data and simulation via computational models. We are especially interested in projects with clinical applications that have the potential to improve diagnosis or treatment of a neurological condition.
The focus of the laboratory is to evaluate underlying molecular and cellular mechanisms contributing to neuroinflammation, neurodegeneration, and repair in pre-clinical models of neurologic disease.
Our primary goal is to understand molecular mechanisms of natural and synthetic enzymes that perform various types of chemical modifications on nucleic acids to engineer safer gene therapies.
Our laboratory is dedicated to identifying the mechanisms influencing drug use to discover novel therapeutic interventions that could help with cessation.
Undergraduates: invited to get in touch
Website checked
A little unsure where to start?
You don’t need to have your whole research path figured out.